摘要:
Provided are oligopeptide antigens to AI4-like T cells, and mouse proteins comprising those antigens. The oligopeptide antigens comprise the amino acid sequence XX(I/D/F/L)ENY(I/L)(E/W/Y)(L/M) or VMLENYTHL. Additionally provided are methods for treating a mammal having or at risk for type 1 diabetes using these antigens, or compounds which reduce or eliminate expression of these antigens. Kits comprising these antigens, and methods for determining whether a mammal is at risk for or has type 1 diabetes are also provided.
摘要翻译:提供对于类似Aβ的T细胞的寡肽抗原,以及包含这些抗原的小鼠蛋白质。 寡肽抗原包含氨基酸序列XX(I / D / F / L)ENY(I / L)(E / W / Y)(L / M)或VMLENYTHL。 另外提供了使用这些抗原治疗患有或具有1型糖尿病风险的哺乳动物的方法,或减少或消除这些抗原表达的化合物。 还提供了包含这些抗原的试剂盒,以及用于确定哺乳动物是否处于或已经具有1型糖尿病的风险的方法。
摘要:
Provided are polypeptides that are capable of binding a human HLA-A2 MHC class I molecule. Kits comprising these polypeptides in a container are also provided. Further provided are methods for determining whether a mammal is at risk for or has type 1 diabetes. Additionally provided are methods of preventing a CD8+ T cell that is cytotoxic to pancreatic islet β-cells from destroying a β-cell. Methods of treating a mammal that is at risk for type 1 diabetes are also provided, as are methods of treating a mammal that has type 1 diabetes.
摘要:
Provided are oligopeptide antigens to A14-like T cells, and mouse proteins comprising those antigens. The oligopeptide antigens comprise the amino acid sequence XX(I/D/F/L)ENY(I/L)(E/W/Y)(L/M) or VMLENYTHL. Additionally provided are methods for treating a mammal having or at risk for type 1 diabetes using these antigens, or compounds which reduce or eliminate expression of these antigens. Kits comprising these antigens, and methods for determining whether a mammal is at risk for or has type 1 diabetes are also provided.
摘要翻译:提供对A14样T细胞的寡肽抗原,以及包含那些抗原的小鼠蛋白质。 寡肽抗原包含氨基酸序列XX(I / D / F / L)ENY(I / L)(E / W / Y)(L / M)或VMLENYTHL。 另外提供了使用这些抗原治疗患有或具有1型糖尿病风险的哺乳动物的方法,或减少或消除这些抗原表达的化合物。 还提供了包含这些抗原的试剂盒,以及用于确定哺乳动物是否处于或具有1型糖尿病风险的方法。